Werfen to acquire Omixon expanding its portfolio in transplant diagnostics
Barcelona, Spain May 15, 2024.- Werfen announced today that it has agreed to acquire Omixon, a privately held corporation with an innovative portfolio in transplant diagnostics headquartered in Budapest, Hungary. The acquisition will allow Werfen to expand its portfolio of transplant diagnostics solutions for hospitals and clinical laboratories.